Title : Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia.

Pub. Date : 2019 Mar 1

PMID : 30535122






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Standard linezolid dosing in obese pneumonia patients with MRSA (MICs of 1-4 mg/L) leads to unacceptably low (near zero to 60%) PTA for patients <65 years old. Linezolid solute carrier family 9 member A6 Homo sapiens
2 Body weight and especially age are important characteristics to be considered when administering linezolid to treat MRSA infections. Linezolid solute carrier family 9 member A6 Homo sapiens